Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 89 Schemes (26.72%)
Foreign Institutions
Held by 229 Foreign Institutions (9.78%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
41 Million
(Quarterly Results - Mar 2026)
Net Profit:
-93 Million
Pharmaceuticals & Biotechnology
USD 1,877 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.35
-999,999.00%
0.73






